Retractable Technologies, Inc.
Long
Updated

RVP SYRINGE PLAY

172
I have high expectations for RVP, there is currently a large needle shortage worldwide for Covid vaccines and RVP is the leading manufacturer of automated retraction syringes.
RVP's EPS went from .014 to .5 in one year, growing earnings and revenue. RVP is held by 54% insiders. although an insider sold 3m of his shares, it only reduced insider holdings by 1.3%.
price bounced nicely off the 200ma on Jan 14 and hasn't come back to test it. RVP was mentioned by Motley Fool on Friday again.
My entries are in the mid 12s with a target of 20.
Trade active
took profits around 16.30, will re-enter at dip for long shares

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.